Novo Nordisk A/S (NONOF)
OTC: NONOF
· Real-Time Price · USD
52.37
2.11 (4.20%)
At close: Aug 15, 2025, 3:44 PM
51.00
-2.61%
Pre-market: Aug 15, 2025, 11:51 AM EDT
Novo Nordisk A/S Cash Flow Statement
Financials in DKK. Fiscal
year is
undefined.
Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | 29.03B | 28.23B | 27.3B | 20.05B | 25.41B | 21.96B | 22.48B | 19.43B | 19.81B | 13.59B | 14.4B | 13.32B | 14.21B | 10.89B | 12.12B | 12.12B | 12.62B |
Depreciation & Amortization | 3.83B | 5.2B | 2.15B | 8.85B | 2.91B | 2.99B | 2.52B | 2.18B | 1.72B | 2.04B | 2.04B | 1.64B | 1.65B | 2.08B | 1.35B | 1.22B | 1.38B |
Stock-Based Compensation | n/a | n/a | n/a | n/a | n/a | 2.15B | n/a | n/a | n/a | 1.54B | n/a | n/a | n/a | 1.04B | n/a | n/a | n/a |
Other Working Capital | -16.43B | -981M | -11.26B | 9.1B | -8.85B | 1.93B | 11.67B | -4.01B | -10.22B | 14.38B | -11.01B | 4.09B | 1.89B | 153M | 293M | 2.87B | -1.13B |
Other Non-Cash Items | 156M | -27.47B | 18.58B | 30.2B | 673M | -34.96B | 1.99B | 10.71B | 13.57B | -12.48B | 15.18B | 1.44B | 2.12B | -18.94B | 5.47B | 8.14B | 1.03B |
Deferred Income Tax | 8B | 7.33B | 7.08B | 5.28B | 6.51B | 5.66B | 5.58B | 4.83B | 4.92B | 2.72B | 3.63B | 3.48B | 3.71B | 2.22B | 2.99B | 2.79B | 3.31B |
Change in Working Capital | -16.43B | -981M | -11.26B | 9.1B | -8.85B | -9.68B | 11.67B | -4.01B | -10.22B | -308M | -11.01B | 4.09B | 1.89B | -10.69B | 293M | 2.87B | -1.13B |
Operating Cash Flow | 24.59B | 12.3B | 43.85B | 50.5B | 14.31B | 9.55B | 40.97B | 28.58B | 29.81B | 7.1B | 24.24B | 23.96B | 23.59B | -3.02B | 21.51B | 25.25B | 11.26B |
Capital Expenditures | -14.59B | -16.56B | -12.12B | -13.24B | -9.01B | -16.44B | -10.62B | -7.04B | -4.8B | -6.17B | -4.22B | -2.58B | -1.78B | -2.31B | -1.69B | -1.88B | -1.5B |
Cash Acquisitions | n/a | -81.5B | 1M | -668M | n/a | 7.03B | 4.8B | 1.16B | 1.95B | -7.08B | 995M | 140M | 260M | -18.28B | 513M | 175M | 97M |
Purchase of Investments | -115M | -353M | -8.44B | -9.87B | -1.16B | -948M | -4.83B | -5.15B | -2.36B | -3.12B | -1.71B | -3.06B | -1.85B | -228M | -3.13B | -1.41B | -2.35B |
Sales Maturities Of Investments | 8.03B | 7.19B | 35M | 3.04B | 14.13B | 2.67B | 2.21B | 2.9B | 515M | 2.52B | 970M | 1.43B | 1.73B | 222M | 179M | 403M | 368M |
Other Investing Acitivies | -1.16B | -458M | -385M | -9.59B | 12.43B | -7.03B | -4.8B | -1.16B | -1.95B | -1.81B | -995M | -140M | -260M | -271M | -513M | -175M | -93M |
Investing Cash Flow | -6.67B | -91.22B | -20.9B | -20.73B | 3.96B | -14.72B | -13.24B | -9.29B | -6.65B | -13.85B | -4.96B | -4.2B | -1.91B | -20.6B | -4.63B | -2.89B | -3.48B |
Debt Repayment | 15.33B | 44.33B | -413M | 29.46B | -317M | -355M | -261M | -373M | -478M | -129M | -330M | -244M | -1.71B | 12.06B | -175M | 3.93B | -349M |
Common Stock Repurchased | -1.39B | -7.49B | -2.4B | -7.45B | -2.84B | -9.76B | -6.14B | -8.82B | -5.2B | -7.54B | -4.62B | -7.45B | -4.48B | -7.51B | -3.54B | -5.44B | -2.96B |
Dividend Paid | -35.27B | n/a | -15.58B | n/a | -28.56B | n/a | -13.43B | n/a | -18.34B | n/a | -9.61B | n/a | -15.69B | n/a | -8.02B | -1M | -13.49B |
Other Financial Acitivies | 26.78B | n/a | n/a | -39.84B | 5.33B | n/a | n/a | -3.39B | 3.39B | n/a | n/a | -2.74B | 2.74B | n/a | n/a | -2.33B | 2.33B |
Financial Cash Flow | 5.45B | 36.84B | -18.4B | 16.68B | -26.38B | -10.12B | -19.83B | -12.59B | -20.62B | -7.67B | -14.56B | -10.43B | -19.14B | 4.55B | -11.73B | -3.84B | -14.47B |
Net Cash Flow | 23.28B | -41.36B | 4.2B | 46.5B | -8.07B | -15.49B | 8.31B | 6.64B | 2.28B | -15.26B | 5.16B | 9.55B | 2.49B | -18.77B | 5.26B | 18.55B | -6.55B |
Free Cash Flow | 10.01B | -4.26B | 31.73B | 37.27B | 5.3B | -6.88B | 30.34B | 21.54B | 25.01B | 928M | 20.01B | 21.39B | 21.81B | -5.33B | 19.82B | 23.37B | 9.76B |